<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
a:link, span.MsoHyperlink
	{color:#0563C1;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU link="#0563C1" vlink="#954F72">

<div class=WordSection1>

<h1><span lang=EN-US>PM01 2020: Opioids in chronic non-cancer pain</span></h1>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>List:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Summary</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Associated problems</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Assessment</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Alternatives</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Opioid trialling</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tolerance</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Opioid weaning</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Summary:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>No good in chronic non-cancer pain, even if pain
score is high</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Plenty of harm: tolerance, dependence,
addiction, overdose, sleep apnoea, cognitive impairment, unsafe driving, falls,
osteoporosis, sexual dysfunction, constipation</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Especially dangerous in combination with
alcohol, benzodiazepines</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Once started, very difficult to stop</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Diverts focus from alternatives (see below)</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Associated problems:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Multiple pain conditions</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Social problems: unemployment, welfare
dependence</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Psych problems: childhood abuse/neglect,
depression, alcohol</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Risk factors for misuse: youth, absence of
medical diagnosis, psychiatric disorder, other drug use, contact with drug user</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Assessment:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pain history: time course, quality (including
neuropathic)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Psychological state: including beliefs, mood
state, behaviours, responses</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Social environment</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Risk assessment for misuse</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Alternatives:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>MDT: pain specialist, psychologist/psychiatrist,
addiction med, rehabilitation med, physiotherapy, occupational therapy,
dietician, social worker</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Basic: housing, nutrition, sleep hygiene,
exercise, work, social engagement</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Psych: CBT, mindfulness, neuroscience education</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesics: paracetamol, (NSAIDs if
inflammation), TCAs, SNRI, gabapentinoids</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>If trialling an opioid:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>State the plan and goals</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Monitor 5As: <b>A</b>nalgesia, <b>A</b>ctivity, <b>A</b>dverse
effects, <b>A</b>ffect, <b>A</b>berrant behaviour</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Use long-acting drug drug (minimizes positive
reinforcement)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Titrate over several weeks</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ceiling effect controversial; oMEDD caution
&gt;40, not good &gt;100</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Note lowest dose fentanyl patch (12mcg/h) is
close to oMEDD 40mg</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>If opioid stops working:</span></h2>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Drug problems: tolerance -&gt; ↓effect
↓duration, side effects</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Psychosocial problems: aberrant behaviour, life
problems</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Rotate opioid if suspect tolerance</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Opioid weaning after long-term use:</span></h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Aim for cessation within 3-9 months</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Aim 10-25% dose per week; slower if not
tolerated</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If significant adverse effects or misuse,
suggest daily reduction or cold turkey</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Addiction may become apparent; if so, refer to
appropriate service</span></p>

<p class=MsoNormal style='margin-bottom:0cm'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0cm'>Feedback welcome at <a
href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>

<p class=MsoNormal style='margin-bottom:0cm'>&nbsp;</p>

</div>

</body>

</html>
